2015 NET INCOME FOR THE YEAR OF C-QUADRAT INVESTMENT AG

11.04.2016, 3456 Zeichen

Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.
annual result
.) Group's net profit for the year amounts to EUR 20.7 million (2014: EUR 22.4 million) .) Dividend proposal for shareholders' meeting: EUR 4.0 per share (2014: EUR 3.0 per share)
In 2015 C-QUADRAT Investment AG realized another highly successful financial year, the second-best in its 25-year history. Above all, this success reflected healthy core business, further growth in the volume of assets under its management thanks to the performance of C-QUADRAT's funds and the expansion of its sales activities.
As of the balance sheet date, C-QUADRAT Investment AG had increased the total volume of assets under its management by approx. 4% to EUR 5.4 billion. Due to a changeover of commission payment procedures - funds of C-QUADRAT Kapitalanlagegesellschaft have been outsourced to external management companies - an annual comparison of the total revenue from regular management fees and performance-related management fees for the years 2014 and 2015 is not possible. All in all, total revenues remained at a high level (2015: EUR 83.8 million; 2014: EUR 94.9 million). Moreover, the solid performance of the funds of C- QUADRAT and its subsidiaries once again generated considerable performance- related management fees, in the amount of EUR 31.2 million. Net fee and commission income excluding performance-related management fees increased to EUR 22.4 million (2014: EUR 21.2 million)
In terms of costs, personnel expenses were reduced by 5% to EUR 11.0 million, while other administrative expenses and other operating expenses have declined by 1.2% to EUR 9.6 million.
The associates likewise once again all provided significant contributions to consolidated earnings. Net income from associates amounted to EUR 7.4 million.
In overall terms, in 2015 a net profit for the year (after taxes) of EUR 20.7 million (2014: EUR 22.4 million) was realized.
Earnings per share amount to EUR 4.59 (2014: EUR 5.05). The dividend proposal is EUR 4.0 per share (2014: EUR 3.0 per share). Dividend day has been moved from May 23, 2016 to June 22, 2016. The updated financial calendar is available at www.c-quadrat.at in the Investor Relations section.
C-QUADRAT founder and management board member Alexander Schütz says of these results: "In 2015, C-QUADRAT achieved the second-best result in its 25-year history. Thanks to the continuing growth in the volume of assets managed by the C-QUADRAT Group, the company maintained a strong revenue base. We have not quite achieved our cost-cutting goals and will continue to pursue them in 2016. We will continue to follow our company's dual strategy of organic and inorganic growth."
With immediate effect, the 2015 consolidated financial statements and the standalone financial statements of C-QUADRAT Investment AG may be downloaded from the Investor Relations section of its website www.c-quadrat.at.


end of announcement euro adhoc
company: C-QUADRAT Investment AG Schottenfeldgasse 20 A-1070 Wien phone: +43 1 515 66-0 FAX: +43 1 515 66-159 mail: c-quadrat@investmentfonds.at WWW: www.c-quadrat.com

sector: Financial & Business Services
ISIN: AT0000613005 indexes: Standard Market Auction

stockmarkets: official market: Frankfurt, Wien language: English
Digital press kit: http://www.ots.at/pressemappe/3309/aom

Christian Drastil: Wiener Börse Plausch

Börsepeople im Podcast S25/09: Philipp Pölzl

C-Quadrat Investment AG Letzter SK:  0.00 ( 0.00%)

Bildnachweis

1. C Quadrat am Fonds Kongress , (© Martina Draper/photaq)   >> Öffnen auf photaq.com

Aktien auf dem Radar:Polytec Group, Semperit, AT&S, Austriacard Holdings AG, Amag, Kapsch TrafficCom, Zumtobel, Rosenbauer, Rosgix, CA Immo, FACC, Reploid Group AG, Andritz, Mayr-Melnhof, Palfinger, EuroTeleSites AG, Fabasoft, Frequentis, Gurktaler AG Stamm, Porr, voestalpine, BKS Bank Stamm, CPI Europe AG, Österreichische Post, Telekom Austria, Infineon, IBM, Cisco, Nvidia, Fresenius Medical Care, Bayer.

---

Mehr aktuelle OTS-Meldungen HIER